Lycia Therapeutics, Inc. (LYCA)
NASDAQ
$31.77+$0.4200 (+1.34%) on the dayAs of the close; data may be delayed.
LYCA price, last 12 months
Key stats
- Previous close
- $31.35
- Open
- $31.34
- Day range
- $30.71 – $32.87
- 52-week range
- $22.19 – $36.49
- Volume
- 281.8K
- Avg volume (20 days)
- 433.4K
- Market cap
- $1.6B
Performance
1W+6.0%
1M—
3M—
6M—
YTD—
1Y—
About Lycia Therapeutics, Inc.
Lycia Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory and allergic diseases.
- Listed on
- NASDAQ
- Market cap
- $1.6B